FREMONT, Calif.--(BUSINESS WIRE)--FlowMedica, Inc., a medical device company pioneering targeted renal therapy (TRT™), today announced that Gary Saxton has been appointed as President and Chief Executive Officer, effective July 30, 2007.
“Gary brings both extensive strategy development as well as operating experience to FlowMedica, and joins the company as we expand our clinical programs and commercial activities. His experience within the interventional and surgical specialties will help us optimize the many opportunities we have to prevent and treat acute renal injury and renal failure,” said Phil Hopper, Chairman of the Board. “We also look forward to leveraging his business development background to forge alliances with a variety of industry partners.”
